In Vitro Models of Ovarian Cancer: Bridging the Gap between Pathophysiology and Mechanistic Models

Area of Science:

• Oncology
• Biomedical Engineering
• Cancer Research

Background:

• Ovarian cancer (OC) has a low 5-year survival rate (~40%), largely due to late-stage diagnosis (>80% of cases) at advanced metastatic stages.
• The disease is characterized by significant genetic and phenotypic heterogeneity, contributing to high relapse rates and reduced patient survival.
• Understanding OC pathophysiology and improving drug screening necessitate advanced in vitro models that accurately reflect the tumor microenvironment and cellular dynamics.

Purpose of the Study:

• To review the pathophysiology of ovarian cancer.
• To detail engineering strategies for developing advanced in vitro models for OC research.
• To bridge the gap between OC pathophysiology and mechanistic models for clinical applications.

Main Methods:

• Review of existing literature on ovarian cancer pathophysiology.
• Analysis of recent advancements in 3D cell culture techniques.
• Exploration of microfluidic technologies for creating complex cellular models.

Main Results:

• Discussion of OC's complex pathophysiology, including heterogeneity and metastatic potential.
• Highlighting the potential of 3D cell culture and microfluidics in creating more accurate OC models.
• Identification of engineering strategies to recapitulate key biological features of OC.

Conclusions:

• Advanced in vitro models using 3D cell culture and microfluidics are crucial for understanding ovarian cancer.
• These innovative models can enhance drug screening capabilities and provide better mechanistic insights for clinical research.
• Further development in these areas promises to improve outcomes for ovarian cancer patients.